Are MRI white matter lesions clinically significant in the 'old-old'? Evidence from the Sydney Older Persons Study

Dementia and Geriatric Cognitive Disorders

Volumn 15, Issue 3, 2003, Pages 143-150

  Piguet, Olivier ^a,b,c   Ridley, Lloyd ^c   Grayson, David A ^a   Bennett, Hayley P ^b   Creasey, Helen ^a   Lye, Tanya C ^a   Broe, G Anthony ^b,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Aging; Apolipoprotein E; Magnetic resonance imaging; White matter lesion

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ARTICLE; AUSTRALIA; BRAIN INJURY; BRAIN REGION; COGNITION; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GENOTYPE; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; TEMPORAL LOBE; WHITE MATTER;

AGED; AGED, 80 AND OVER; BRAIN; COGNITION DISORDERS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LIFE STYLE; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 12244265495     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068482     Document Type: Article

References (37)

1. Jorm AF, Jolley D: The incidence of dementia: A meta-analysis. Neurology 1998;51:728-733.
2. Christensen H, MacKinnon AJ, Korten AE, Jorm AF, Henderson AS, Jacomb P: Dispersion in cognitive ability as a function of age: A longitudinal study of an elderly community sample. Aging Neuropsychol Cogn 1999;6:214-228.
3. Schaie KW: The course of adult intellectual development. Am Psychol 1994;49:304-313.
4. Xuereb JH, Brayne C, Dufouil C, Gertz H, Wischik C, Harrington C, et al: Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann NY Acad Sci 2000;903:490-496.
5. Silver MH, Newell K, Brady C, Hedley-White ET, Perls TT: Distinguishing between neurodegenerative disease and disease-free aging: Correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med 2002;64:493-501.
6. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L: Incidence of AD may decline in the early 90s for men, later for women: The Cache County Study. Neurology 2002;58:209-218.
7. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, et al: Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999;53:1992-1997.
8. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 1994;44:1246-1252.
9. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
10. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, et al: White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
11. Waite LM, Broe GA, Grayson DA, Creasey H: The incidence of dementia in an Australian community population: The Sydney Older Persons Study. Int J Geriatr Psychiatry 2001;16:680-689.
12. Waite LM, Broe GA, Creasey H, Grayson D, Edelbrock D, O'Toole B: Neurological signs, aging, and the neurodegenerative syndromes. Arch Neurol 1996;53:498-502.
13. Waite LM, Broe GA, Creasey H, Grayson DA, Cullen JS, O'Toole B, et al: Neurodegenerative and other chronic disorders among people aged 75 years and over in the community. Med J Aust 1997;167:429-432.
14. Waite LM, Broe GA, Grayson DA, Creasey H: Preclinical syndromes predict dementia: The Sydney Older Persons Study. J Neurol Neurosurg Psychiatry 2001;71:296-302.
15. Yang JG, Poropat RA, Brooks WS, Broe GA, Nicholson GA: Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample. Aust NZ J Med 1996;26:658-661.
16. World Health Organisation: Mental Disorders: Glossary and Guide to Their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. Geneva, World Health Organisation, 1978.
17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
18. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987;149:351-356.
19. Scheltens P, Erkinjunti T, Leys D, Wahlund LO, Inzitari D, del Ser T, et al: White matter changes on CT and MRI: An overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998;39:80-89.
20. de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, et al: Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000;47:145-151.
21. Miller EN: CalCAP California Computerized Assessment Package Manual. Los Angeles, Norland Software, 1996.
22. Wechsler D: WMS-R Manual. New York, Psychological Corporation, 1987.
23. Kaplan EF, Goodglass J, Weintraub S: The Boston Naming Test, ed 2. Philadelphia, Lea & Febiger, 1983.
24. Benton AL, Hamsher KdeS, Varney NR, Spreen O: Contributions to Neuropsychological Assessment. New York, Oxford University Press, 1983.
25. Wechsler D: WAIS-R Manual. New York, Psychological Corporation, 1981.
26. Benton AL, Hamsher K: Multilingual Aphasia Examination. Iowa City, AJA Associates, 1983.
27. Ruff RM: Ruff Figural Fluency Test Administration Manual. San Diego, Neuropsychological Resources, 1988.
28. Radloff LS: The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
29. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
30. Ivnik RJ, Malec JF, Smith GE, Tangalos EG: Neuropsychological tests' norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO. Clin Neuropsychol 1996;10:262-278.
31. Smith GE, Wong JS, Ivnik RJ, Malec JF: Mayo's Older American Normative Studies: Separate norms for WMS-R Logical Memory stories. Assessment 1997;4:79-86.
32. Boone KB, Miller BL, Lesser IM, Mehringer M, Hill-Gutierrez E, Goldberg MA, et al: Neuropsychological correlates of white-matter lesions in healthy elderly subjects: A threshold effect. Arch Neurol 1992;49:549-554.
33. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al: Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9-14.
34. Piccini P, Pavese N, Canapicchi R, Paoli C, Del Dotto P, Puglioli M, et al: White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol 1995;52:191-194.
35. Desmond DW: Cognition and white matter lesions. Cerebrovasc Dis 2002;13(suppl 2):53-57.
36. Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Backman L: White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626-632.
37. Skoog I, Berg S, Johansson B, Palmertz B, Andreasson LA: The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds. Acta Neurol Scand 1996;93:142-148.